Pharmacotherapy, namely the stimulant medications methylphenidate (MPH) and amphetamine (MAS) and the nonstimulant medication atomoxetine (Strattera), is the recommended treatment for attention-deficit/hyperactivity disorder (ADHD).
Avram Z. Traum, MD
Advertisement
Articles by Avram Z. Traum, MD
Advertisement
Latest Updated Articles
- Cardiovascular risk in ADHD pharmacotherapy
Published: November 1st 2009 | Updated:
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FDA approves aflibercept injection 8 mg to treat macular edema and monthly dosing
2
Early genetic testing may reshape care for inherited connective tissue disorders in children
3
Alice Hoyt, MD, discusses the importance of quick epinephrine use for anaphylaxis
4
Roflumilast Efficacy and Safety in Pediatric AD
5
